CoChat

Link Between GIP and Osteopontin in Adipose Tissue and Insulin Resistance

Open access

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

Low-grade inflammation in obesity is associated with accumulation of the macrophage-derived cytokine osteopontin (OPN) in adipose tissue and induction of local as well as systemic insulin resistance. Since glucose-dependent insulinotropic polypeptide (GIP) is a strong stimulator of adipogenesis and may play a role in the development of obesity, we explored whether GIP directly would stimulate OPN expression in adipose tissue and thereby induce insulin resistance. GIP stimulated OPN protein expression in a dose-dependent fashion in rat primary adipocytes. The level of OPN mRNA was higher in adipose tissue of obese individuals (0.13 ± 0.04 vs. 0.04 ± 0.01, P < 0.05) and correlated inversely with measures of insulin sensitivity (r = -0.24, P = 0.001). A common variant of the GIP receptor (GIPR) (rs10423928) gene was associated with a lower amount of the exon 9-containing isoform required for transmembrane activity. Carriers of the A allele with a reduced receptor function showed lower adipose tissue OPN mRNA levels and better insulin sensitivity. Together, these data suggest a role for GIP not only as an incretin hormone but also as a trigger of inflammation and insulin resistance in adipose tissue. Carriers of the GIPR rs10423928 A allele showed protective properties via reduced GIP effects. Identification of this unprecedented link between GIP and OPN in adipose tissue might open new avenues for therapeutic interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db12-0976

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Expression of the GIPR in adipose tissue. A: Immunostainings demonstrating that GIPR (green) is abundantly expressed in human, mouse, and rat white adipose tissue (top) and skeletal muscle (bottom). Scale bar, 50 µm. B: Agarose gel electrophoresis of RT-PCR across the variable part of GIPR cDNA (from exon 2 to 10) from SAT and VAT samples from seven individuals. The size of the predicted functional GIPR amplicon of 887 bp is indicated, as well as the size range of identified splice variants (green bars). C: Schematic representation of alternative splicing of the full-length GIPR. Black exons are obligatory and colored are variable. Dashed lines indicate rare events. Exon 1, which is noncoding, is presumably variable. Exons 3 and 5 possess alternative splice sites. The GIP binding site (HormR) and the transmembrane domain (7tm_2) are indicated. Transmembrane helices (gray) I, II, III, and VI are encoded by single exons. Splice variants were detected by RT-PCR and sequencing. Variants predicted to yield a fully functional membrane-bound GIPR are indicated by asterisks. D: Proportion of full mRNA splice variants including exon 9 is decreased in the adipose tissue of subjects with the A allele of rs10423928 (ANOVA, P < 0.05). PCR primers are shown in exons 8 and 11. Variant ratios were detected using PCR and capillary electrophoresis. Peak areas were used to calculate the relative quantities of the PCR products.
FIG. 1. Expression of the GIPR in adipose tissue. A: Immunostainings demonstrating that GIPR (green) is abundantly expressed in human, mouse, and rat white adipose tissue (top) and skeletal muscle (bottom). Scale bar, 50 µm. B: Agarose gel electrophoresis of RT-PCR across the variable part of GIPR cDNA (from exon 2 to 10) from SAT and VAT samples from seven individuals. The size of the predicted functional GIPR amplicon of 887 bp is indicated, as well as the size range of identified splice variants (green bars). C: Schematic representation of alternative splicing of the full-length GIPR. Black exons are obligatory and colored are variable. Dashed lines indicate rare events. Exon 1, which is noncoding, is presumably variable. Exons 3 and 5 possess alternative splice sites. The GIP binding site (HormR) and the transmembrane domain (7tm_2) are indicated. Transmembrane helices (gray) I, II, III, and VI are encoded by single exons. Splice variants were detected by RT-PCR and sequencing. Variants predicted to yield a fully functional membrane-bound GIPR are indicated by asterisks. D: Proportion of full mRNA splice variants including exon 9 is decreased in the adipose tissue of subjects with the A allele of rs10423928 (ANOVA, P < 0.05). PCR primers are shown in exons 8 and 11. Variant ratios were detected using PCR and capillary electrophoresis. Peak areas were used to calculate the relative quantities of the PCR products.CC BY-NC-ND · PubMed Central
FIG. 2. Effects of GIP and GIPR genotype on OPN expression in adipocytes. A: Correlation between OPN mRNA in adipose tissue and ISI in different GIPR SNP rs10423928 carriers (Danish Twins Study, n = 83) (TT, black solid lines and gray circles; TA/AA, dashed lines and empty circles). B: Expression of OPN mRNA was lower in adipose tissue from TA/AA vs. TT genotype carriers (Danish Twins Study, *P < 0.05). C: GIP stimulation induces OPN in primary rat adipocytes. Adipocytes were isolated from rat epididymal fat pads and incubated overnight (∼18 h) in media containing either 5 or 25 mmol/L glucose in the presence of GIP and insulin at the indicated concentrations. Data are presented as mean ± SEM of OPN protein expression relative to β-actin, expressed as percent of control cell (25 mmol/L glucose) expression. n = 6–12 per condition. *P < 0.05; **P < 0.01; ***P < 0.001.
FIG. 2. Effects of GIP and GIPR genotype on OPN expression in adipocytes. A: Correlation between OPN mRNA in adipose tissue and ISI in different GIPR SNP rs10423928 carriers (Danish Twins Study, n = 83) (TT, black solid lines and gray circles; TA/AA, dashed lines and empty circles). B: Expression of OPN mRNA was lower in adipose tissue from TA/AA vs. TT genotype carriers (Danish Twins Study, *P < 0.05). C: GIP stimulation induces OPN in primary rat adipocytes. Adipocytes were isolated from rat epididymal fat pads and incubated overnight (∼18 h) in media containing either 5 or 25 mmol/L glucose in the presence of GIP and insulin at the indicated concentrations. Data are presented as mean ± SEM of OPN protein expression relative to β-actin, expressed as percent of control cell (25 mmol/L glucose) expression. n = 6–12 per condition. *P < 0.05; **P < 0.01; ***P < 0.001.CC BY-NC-ND · PubMed Central
FIG. 3. Diagram of the design and summary of the study. DEXA, dual-energy X-ray absorptiometry. P-GIP, plasma-GIP.
FIG. 3. Diagram of the design and summary of the study. DEXA, dual-energy X-ray absorptiometry. P-GIP, plasma-GIP.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 96

Metadata

Authors
Ahlqvist, E., Osmark, P., Kuulasmaa, T., Pilgaard, K., Omar, B., Brøns, C., Kotova, O., Zetterqvist, A. V., Stančáková, A., Jonsson, A., Hansson, O., Kuusisto, J., Kieffer, T. J., Tuomi, T., Isomaa, B., Madsbad, S., Gomez, M. F., Poulsen, P., Laakso, M., Degerman, E., Pihlajamäki, J., Wierup, N., Vaag, A., Groop, L., & Lyssenko, V.
Affiliations
  • Lund University (SE)
  • University of Eastern Finland (FI)
  • Steno Diabetes Center, Gentofte, Denmark
  • University of British Columbia (CA)
  • Folkhalsan Research Centre, Helsinki, Finland
  • Folkhälsans Forskningscentrum (FI)
  • University of Copenhagen (DK)
  • University of Helsinki (FI)
Corresponding author
Lyssenko, Valeriya
Venue
Diabetes
Published
2013-05-17
Volume
62
Issue
6
Pages
2088-2094
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2159566085
Cited by
96
References
20
Citations by year
2026: 4 · 2025: 3 · 2024: 7 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 8 · 2019: 14 · 2018: 5 · 2017: 7 · 2016: 9 · 2015: 12 · 2014: 8 · 2013: 6
FWCI
8.42
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders
  • Lunds Universitet
  • Novo Nordisk Fonden (NNF12OC1016467)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
glucose-dependent insulinotropic polypeptide, osteopontin, insulin resistance, adipose tissue, obesity, low-grade inflammation, GIP receptor, adipocytes, incretins, adipogenesis, insulin sensitivity
MeSH terms
Adipose Tissue, Adolescent, Adult, Aged, Alleles, Animals, Cells, Cultured, Female, Gastric Inhibitory Polypeptide, Humans, Insulin Resistance, Male, Middle Aged, Receptors, Gastrointestinal Hormone, Mice, Rats, Osteopontin, Young Adult, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.